This Center grant requests funding for seven Core facilities to support a broadly-based research program in the study of mental retardation and developmental disabilities. The seven Core facilities are: Administrative, Multimedia, Image Graphics/Confocal, Cellular Neuroscience, Gene Manipulation, Molecular Genetics, and Cell Sorter. The Cores, which are derived from the previous 10 Core facilities of the Center, have undergone major development and support the research of 49 investigators who receive approximately $14,700,000 in external funding, approximately $13,000,000 of which is from the NIH. The research is in two programmatic areas, i.e., Genetics and Neuroscience. In Genetics, directed by Dr. Louis Kunkel, there are five major research efforts: molecular genetics of neuromuscular disease, genetic imprinting in Angelman and Prader-Willi syndromes, molecular diagnosis, dystrophin-related proteins in brain, and somatic cell genetics. In Neuroscience, there are three major programs, i.e., Basic Neuroscience, directed by the newly- recruited Associate Director of the Center, Dr. Michael Greenberg; Clinical Neuroscience/Behavior, directed by the Center Director; and Developmental Biology, directed by Dr. Merton Bernfield. The Basic Neuroscience Program consists of 23 funded investigators whose research efforts span a broad spectrum of interdigitated research in molecular, cellular, ultrastructural, and systems neuroscience, with a strong overall emphasis on development. A research project in Basic Neuroscience, proposed in this grant as a """"""""New Program"""""""", addresses """"""""Mechanisms of Glutamate- Mediated Immediate Early Gene Expression"""""""" (Stephen Finkbeiner, M.D., Ph.D). A second major program in Neuroscience, i.e., Clinical Neuroscience/Behavior, directed by the Center Director, has undergone marked development in terms of investigators and scope of research. The research areas include: ischemic neonatal brain injury, neurocardiology, behavioral and neurophysiological development, developmental psychology and learning disturbances, development of human visual function, HIV and the developing nervous system, and effects of endogenous and exogenous toxins on brain development. These areas of clinical research interdigitate with the basic research in the MRRC. A third exciting program in Neuroscience, i.e., Developmental Biology, directed by Dr. Merton Bernfield, addresses fundamental mechanisms of cellular organization during embryonic development, particularly the interaction of cell surface molecules with the extracellular matrix. The multidisciplinary approaches to the research of this MRRC include the various basic science disciplines within Genetics and Neuroscience, and the clinical science fields of Neurology, Pediatrics, Neonatology, Infectious Disease, Endocrinology, Metabolism, Genetics, Cardiology, Neurosurgery, Neuropathology, Ophthalmology, Psychiatry, and Psychology. The basic science programs are housed in over 50,000 sq. ft. of the Enders Pediatric Research Building. The clinical research programs are centered in the adjacent Children's Hospital.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Center Core Grants (P30)
Project #
5P30HD018655-16
Application #
2403122
Study Section
Mental Retardation Research Committee (HDMR)
Project Start
1996-08-01
Project End
2001-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
16
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Hirschberger, Rachel G; Kuban, Karl C K; O'Shea, Thomas M et al. (2018) Co-occurrence and Severity of Neurodevelopmental Burden (Cognitive Impairment, Cerebral Palsy, Autism Spectrum Disorder, and Epilepsy) at Age Ten Years in Children Born Extremely Preterm. Pediatr Neurol 79:45-52
Korzeniewski, Steven J; Allred, Elizabeth N; O'Shea, T Michael et al. (2018) Elevated protein concentrations in newborn blood and the risks of autism spectrum disorder, and of social impairment, at age 10 years among infants born before the 28th week of gestation. Transl Psychiatry 8:115
Sveinsdóttir, Kristbjörg; Ley, David; Hövel, Holger et al. (2018) Relation of Retinopathy of Prematurity to Brain Volumes at Term Equivalent Age and Developmental Outcome at 2 Years of Corrected Age in Very Preterm Infants. Neonatology 114:46-52
Gilles, Floyd; Gressens, Pierre; Dammann, Olaf et al. (2018) Hypoxia-ischemia is not an antecedent of most preterm brain damage: the illusion of validity. Dev Med Child Neurol 60:120-125
Laprairie, Robert B; Petr, Geraldine T; Sun, Yan et al. (2018) Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1. Neurochem Int :
Kambara, Tracy K; Ramsey, Kathryn M; Dove, Simon L (2018) Pervasive Targeting of Nascent Transcripts by Hfq. Cell Rep 23:1543-1552
Leviton, Alan; Allred, Elizabeth N; Fichorova, Raina N et al. (2018) Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage. Eur J Paediatr Neurol 22:440-450
van der Burg, Jelske W; O'Shea, T Michael; Kuban, Karl et al. (2018) Are Extremely Low Gestational Age Newborns Born to Obese Women at Increased Risk of Cerebral Palsy at 2 Years? J Child Neurol 33:216-224
Joyal, Jean-Sébastien; Gantner, Marin L; Smith, Lois E H (2018) Retinal energy demands control vascular supply of the retina in development and disease: The role of neuronal lipid and glucose metabolism. Prog Retin Eye Res 64:131-156
Robinson, Shenandoah; Corbett, Christopher J; Winer, Jesse L et al. (2018) Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury. Exp Neurol 302:1-13

Showing the most recent 10 out of 1442 publications